Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

KYNE bolsters digital offering

KYNE bolsters digital offering Prior to launching Medit, O’Donnell led digital and social marketing integration at Lundbeck.

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug Lundbeck bolstered its R&D pipeline ahead of the weekend with a 900m ($1.1bn) deal to acquire Prexton Therapeutics and its mid-stage Parkinson’s disease (PD) candidate foliglurax. ... Lundbeck says data from the phase II trial is due early next year,

Metrion Biosciences establishes scientific advisory board

Metrion Biosciences establishes scientific advisory board Dr Reynolds has served in numerous positions at Merck, Lundbeck and Pfizer.

Fujitsu begins two-year medical AI research project

Fujitsu begins two-year medical AI research project Meanwhile, last year saw an uptick in life sciences interest in applying AI to drug research, with the likes of Scotland’s Exscientia scoring deals withand Sanofi, and Lundbeck signing up

Teva sheds R&D chief after new CEO takes the helm

Teva sheds R&D chief after new CEO takes the helm at Lundbeck - and shares in Teva closed up 5.3% in the wake of the announcement.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics